Publications by authors named "Thomas Held"

Claim this Profile
I
Intensity-modulated radiotherapy with carbon ion boost for high-risk sinonasal squamous cell carcinoma: clinical outcomes and the management of the node-negative neck.
Lukas Bauer, Katharina Weusthof, Sebastian Regnery, Maximilian Deng, Philipp Schröter, Thomas Held

Clin Transl Radiat Oncol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes of modern radiation therapy for pituitary adenoma - different techniques: single institute experience.
Alexandra Brand, Linda Agolli, Kerem Tuna Tas, Phillip Lishwiski, Markus Schymalla, Thomas Held

J Neurooncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Particle Therapy in the Multimodal Treatment for Locally Advanced Malignancies of the Nasal Cavity and Paranasal Sinus-Single Institute Experience.
Fatima Frosan Sheikhzadeh, Gertrud Schmich, Niklas Recknagel, Edgar Smalec, Tasneim Abdelrahman Mohamed, Thomas Held

Adv Radiat Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and recurrence pattern analysis of intensity modulated chemoradiotherapy in nasopharyngeal cancer: a retrospective study from Heidelberg University Hospital.
Lukas Bauer, Sebastian Regnery, Maximilian Y Deng, Florian Stritzke, Philipp Schröter, Thomas Held

Radiat Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postoperative radiotherapy in subtotally resected recurrent WHO grade 1 meningiomas with intermediate-/high-risk molecular profiles.
Maximilian Y Deng, Sybren L N Maas, Günes Anil, Philipp Sievers, Jonathan Lischalk, Thomas Held

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized controlled trial of semi-individualized 3D-printed tissue retraction devices vs. standard shielding splints in head and neck cancer treated with intensity-modulated and particle radiotherapy (GUARD).
Philipp Schröter, Leo Vincent Christ, Katharina Dvornikovich, Florian Stritzke, Henrik Franke, Thomas Held

Oral Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Photoacoustic imaging for monitoring radiotherapy treatment response in head and neck tumors.
Niklas Holzwarth, Zoe Rachel, Jan-Hinrich Nölke, Melanie Schellenberg, Lukas Bauer, Thomas Held

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Spatial and Dosimetric Recurrence Pattern Analysis in Head and Neck Squamous Cell Carcinoma Following Postoperative (Chemo)radiotherapy.
Philipp Schröter, Hoi Hin Lau, Florian Stritzke, Henrik Franke, Katharina Weusthof, Thomas Held

Radiat Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-grade, metastatic disease, and adjuvant radiotherapy are independent prognostic factors for progression-free survival in patients with solitary fibrous tumors.
Jan Paul Alker, Ramin Rahmanzade, Thomas Held, Christel Herold-Mende, Andreas Unterberg

Neurooncol Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapy.
Florian Janke, Florian Stritzke, Katharina Dvornikovich, Henrik Franke, Arlou Kristina Angeles, Thomas Held

Int J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pembrolizumab in combination with radiochemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: results of the KEYNOTE-412 study and the challenges of radioimmunotherapy].
Florian Stritzke, Thomas Held

Strahlenther Onkol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy Effects on Airway Management in Patients with Nasopharyngeal Cancer.
Davut D Uzun, Timo N Zimmermann, Felix C F Schmitt, Peter K Plinkert, Markus A Weigand, Thomas Held

Cancers (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bimodal intensity-modulated radiotherapy in combination with carbon ion therapy (C12) of mucosal melanomas - data of the last decade from Heidelberg University Hospital.
Lukas Bauer, Angela Paul, Sebastian Regnery, Maximilian Y Deng, Malte Ellerbrock, Thomas Held

Front Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Standard-of-care systemic therapy with or without SBRT in patients with oligoprogressive breast cancer or NSCLC (CURB oligoprogression): an open-label, randomised, controlled, phase 2 study].
Florian Stritzke, Thomas Held

Strahlenther Onkol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningioma.
Maximilian Y Deng, Sophie Rauh, Günes Anil, Jonathan W Lischalk, Laura Hahnemann, Thomas Held

Neurooncol Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Cavity Squamous Cell Carcinoma: Impact of Clear Margin Distance on Locoregional Control in Patients Undergoing Postoperative Radiotherapy.
Kristin Lang, Thomas Held, Christian Freudlsperger, Karim Plath, Jürgen Hoffmann

Technol Cancer Res Treat· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robustness of carbon-ion radiotherapy against DNA damage repair associated radiosensitivity variation based on a biophysical model.
Hans Liew, Thomas Tessonnier, Stewart Mein, Giuseppe Magro, Lars Glimelius, Thomas Held

Med Phys· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation of resection margins in oral cancer in dependence of tumor stage and subsite - a retrospective cohort study.
Julius Moratin, Dominik Horn, Marcel Oehme, Karl Semmelmayer, Christa Flechtenmacher, Thomas Held

Clin Oral Investig· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Helium Ion Therapy for Advanced Juvenile Nasopharyngeal Angiofibroma.
Line Hoeltgen, Eva Meixner, Philipp Hoegen-Saßmannshausen, Ji-Young Kim, Maximilian Deng, Thomas Held

Cancers (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined Photon and Carbon Ion Radiation Therapy for Sinonasal Malignancies: Results of the HIT-SNT Prospective Phase 2 Trial.
Katharina Weusthof, Thomas Held, Kristin Lang, Zoe E Rachel, Semi B Harrabi

Int J Radiat Oncol Biol Phys· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07).
Maximilian Y Deng, Amanda Salviano da Silva, Pauline Carlotta Göller, Laila König, Henning Schäfer, Thomas Held

BMC Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton Therapy for Advanced Juvenile Nasopharyngeal Angiofibroma.
Line Hoeltgen, Thomas Tessonnier, Eva Meixner, Philipp Hoegen, Ji-Young Kim, Thomas Held

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Treatment of Carcinomas of the Oral Minor Salivary Glands-Oncological Outcome in Dependence of Tumor Entity and Therapeutic Strategies.
Julius Moratin, Dominik Horn, Karl Semmelmayer, Oliver Ristow, Michael Engel, Thomas Held

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy.
Sebastian Regnery, Lukas Leiner, Carolin Buchele, Philipp Hoegen, Elisabetta Sandrini, Thomas Held

Radiat Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification.
Maximilian Y Deng, Felix Hinz, Sybren L N Maas, Günes Anil, Philipp Sievers, Thomas Held

Neurooncol Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis